GlassScriptPhysician profile
Kirk Alan Powers
NPI 1730492570
$1,185.64
in general payments reported to CMS, 2019-2025
14 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $339 · 2022: $407 · 2023: $263 · 2024: $19.71 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $369.25 | 2021-2025 | Ozempic, Rybelsus |
| Currax Pharmaceuticals LLC | $129.52 | 2021-2023 | Contrave, Nexletol, Nexlizet |
| Corcept Therapeutics | $120.50 | 2023-2025 | Korlym |
| Amgen INC. | $115.57 | 2021-2023 | Repatha |
| Amarin Pharma, INC. | $102.15 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $79.12 | 2022-2023 | Farxiga |
| Kowa Pharmaceuticals America, INC. | $75.24 | 2021-2022 | |
| Abbvie INC. | $54.61 | 2021-2023 | |
| Antares Pharma, INC. | $38.05 | 2021 | |
| Lilly USA, LLC | $32.04 | 2022-2024 | Zepbound |
| Regeneron Healthcare Solutions, INC. | $21.19 | 2022 | |
| Avion Pharmaceuticals | $16.68 | 2022 | |
| Ibsa Pharma INC. | $16.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.